Recent Entries

• AlbudAb Based Half-Life Extension Services

  by Gemini Smith June 9, 2023
  To overcome the limitation of the short circulating half-life of small biotherapeutics, a large variety of half-life extension strategies have emerged in the last decades. The half-life of albumin-binding antibody (AlbudAb) was widely used to extend the half-lives of short-lived ...

• Bispecific Antibody Application in Radioimmunotherapy

  by Gemini Smith June 9, 2023
  In cancer therapy, bispecific antibody application in radioimmunotherapy refers to the therapy in which an antibody that targets tumor-associated antigen is used to deliver cytotoxic radiation to tumor cells. BsAbs are capable of binding two or more antigens/receptors at the same time or bringing tw...

• Acyclovir Fleximer

  by Gemini Smith June 9, 2023
  Fleximers are different series of flexible, or “split” purine base analogues designed to learn how nucleobase flexibility affects the recognition, binding, and activity of nucleoside(tide) analogues. There is a purine base scaffold in the fleximers. With this purine base scaffold, the im...

• Midbody

  by Gemini Smith June 9, 2023
  We offer a wide selection of recombinant antibodies for use in midbody research. Mammalian cells have a temporary structure called the midbody, which appears right before the dividing cells completely separate at the conclusion of cytokinesis. In terms of structure, the midbody is made up of a numb...

• TCR-T and CAR-T/NK Cytotoxicity Assay

  by Gemini Smith June 9, 2023
  TCR-T and CAR-T/NK Cytotoxicity Assay Small molecule drug candidates, T cell therapy, or antibody-based targeted tumor cell killing are a few examples of immunotherapy techniques that aim to regulate immune responses by encouraging T/NK cell recognition of tumor antigens that can be evaluated using...